Cholesterol inhibits TCR signaling by directly restricting TCR-CD3 core tunnel motility

Yan Chen,Yuwei Zhu,Xiang Li,Wenbo Gao,Ziqi Zhen,De Dong,Buliao Huang,Zhuo Ma,Anqi Zhang,Xiaocui Song,Yan Ma,Changyou Guo,Fan Zhang,Zhiwei Huang
DOI: https://doi.org/10.1016/j.molcel.2022.02.017
IF: 16
2022-04-01
Molecular Cell
Abstract:SummaryCholesterol molecules specifically bind to the resting αβTCR to inhibit cytoplasmic CD3ζ ITAM phosphorylation through sequestering the TCR-CD3 complex in an inactive conformation. The mechanisms of cholesterol-mediated inhibition of TCR-CD3 and its activation remain unclear. Here, we present cryoelectron microscopy structures of cholesterol- and cholesterol sulfate (CS)-inhibited TCR-CD3 complexes and an auto-active TCR-CD3 variant. The structures reveal that cholesterol molecules act like a latch to lock CD3ζ into an inactive conformation in the membrane. Mutations impairing binding of cholesterol molecules to the tunnel result in the movement of the proximal C terminus of the CD3ζ transmembrane helix, thereby activating the TCR-CD3 complex in human cells. Together, our data reveal the structural basis of TCR inhibition by cholesterol, illustrate how the cholesterol-binding tunnel is allosterically coupled to TCR triggering, and lay a foundation for the development of immunotherapies through directly targeting the TCR-CD3 complex.
cell biology,biochemistry & molecular biology
What problem does this paper attempt to address?